F/C AETC Faculty HIV HCV Thursday, March 12, 2015 | 1:30pm EDT Medical Facilitator/Didactic Presenter Todd S. Wills, MD University of South Florida Case.

Slides:



Advertisements
Similar presentations
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Advertisements

March 18, 2014 Joan B. Kernan. SBIRT Curriculum Available Online  National Institute on Drug Abuse (NIDA) & Drexel University College of Medicine: annotated.
Clinical Alliances and Partnerships Raul A. Romaguera, DMD, MPH Division of HIV/AIDS Prevention Centers for Disease Control and Prevention March 11, 2004.
Washington D.C., USA, July 2012www.aids2012.org Access to HCV treatment for people with HIV/HCV Professor Gregory Dore Viral Hepatitis Clinical Research.
Operation H.O.P.E.F.U.L. Sean McIntosh, AS Program Coordinator Faculty, Florida/Caribbean AIDS Education and Training Center.
SBIRT: Screening, Brief Intervention, Referral to Treatment
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Dennis Donovan 1, Melissa Phares 1, Ernie McGarry 1, Julie Taborsky 1, Alyssa Forcehimes 2, Courtney Fitzgerald 2, Mary Hatch-Maillette 1, and K. Michelle.
Maria A. Wamsley, MD Professor of Clinical Medicine UCSF School of Medicine.
Incorporating Behavioral Health in the EHR to Improve Care Insitute of Medicine | November 25, 2013 Brigid McCaw, MD, MS, MPH, FACP Medical Director, Family.
Principles of Drug Addiction Treatment: What Works with Offenders? Rita Dries July 2006.
Addiction Medicine Education, Patient Care and Research Update Alex Walley, MD, MSc Clinical Addiction Research and Education (CARE)
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
Incorporating HIV Prevention into the Medical Care of Persons Living with HIV Ask ∙ Screen ∙ Intervene Developed by: The National Network of STD/HIV Prevention.
“I feel safe here” Mariya Masyukova, Sc. B. Medical Student Aaron Fox, M.D., M.S. Assistant Professor of Medicine, Division of General Internal Medicine.
Treatment of HCV infection among active IDUs Jason Grebely, PhD Lecturer Viral Hepatitis Clinical Research Program National Centre in HIV Epidemiology.
Rehabilitation Programs and Office Follow-up Steven R. Ey, M.D. Medical Director Genesis Chemical Dependency Unit South Coast Medical Center Laguna Beach,
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
HIV and Behavioral Health: An Update from SAMHSA Elinore F. McCance-Katz, MD, PhD Chief Medical Officer Substance Abuse and Mental Health Services Administration.
RYAN WHITE 2012 GRANTEE MEETING HEPATITIS C TREATMENT EXPANSION INITIATIVE WASHINGTON, DC - NOVEMBER 29 th 2012 Implementing HCV Treatment Programs in.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
1 Advancing Recovery: Baltimore Buprenorphine Initiative Tucson Presentation July 29, 2009 Baltimore Substance Abuse Systems.
Lessons learned from implementing an Integrated Behavioral Health model in the provision of services for people living with HIV/AIDS in Puerto Rico Juan.
The Value of Ongoing Evaluation in Adopting Buprenorphine-Naloxone Short-term Taper Gregory S. Brigham, Ph.D. Maryhaven, Columbus, Ohio NIDA CTN Ohio Valley.
Taking drugs if you have ___ is BAD. Increased rates transmission Unprotected sex –Anal intercourse Group sex or multiple partners Internet partners Injection.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Co-occurring Challenges: Leveraging ADAP and ACA to Address Hepatitis C and Substance Use Disorders Daniel Raymond Policy Director Harm Reduction Coalition.
Barriers to Treatment in HCV/HIV Co-infection Todd Wills, MD ETAC Infectious Disease Specialist HEPATITIS C TREATMENT EXPANSION INITIATIVE MULTISITE CONFERENCE.
LDL Program Medical Management Philip E. Johnston, Pharm.D.
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
Emotional and Psychiatric Barriers to Addressing HCV Joan E. Zweben, Ph.D. Executive Director: 14 th Street Clinic and East Bay Community Recovery Project.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Implementation of the Substitution Maintenance Therapy in the framework of the Programme “Overcoming HIV/AIDS Epidemics in Ukraine” Stakeholders meeting.
AIDS Community Health Center Treatment Adherence Program CHC Quality Learning Network AIDS Institute April 12, 2007 Roberto Corales, D.O. Danita Djeloski,
INTRODUCTION TO MOTIVATIONAL INTERVIEWING Lynn S. Massey, LMSW Department of Psychiatry Department of Emergency Medicine University of Michigan.
November 4, Substance Use Disorders Consultation Service (SUDS): Integrating Addiction Services in an Acute Medical Setting Anika Alvanzo, MD, MS.
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Integrating Substance Use Treatment into Primary Care: You can do it! Aaron Fox, MD, MS, Assistant Professor of Medicine Albert Einstein College of Medicine/Montefiore.
PROJECT IN-CARE Chicago’s Positive Charge Project Roman Buenrostro, AIDS Foundation of Chicago Sunday July 22, 2012.
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
InSight into Screening, Brief Intervention, Referral, and Treatment.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Bringing Hepatitis C Treatment into the Medical Home A Pilot Program for Drug Users Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission.
S L I D E 0 Enhanced Uptake of Hepatitis C Treatment in an Opioid Treatment Program in the Direct Acting Antiviral Era Jenna Butner MD 1,2, Julia Shi MD.
“Measuring the Units” Alcohol liaison services (ALS) Louise Poley Consultant Nurse in Substance Misuse Cardiff and Vale University Health Board.
Los Angles LGBT Center Noah Kaplan MSW Alex Adame MSW.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Addressing Unhealthy Substance Use with Older Adults Dawn Matchett,LICSW Hearth, Inc. October 20, 2014.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Kathleen Brady, MD; Coleman Terrell; Marlene Matosky, MPH, RN
Family History Information Helps Inform Chronic Pain Treatment
ADDRESSING THE ACHILLES’ HEEL OF HIV TREATMENT SUCCESS José M
Behavioral Health JPS Health Network Wayne Young, MBA, LPC, FACHE.
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Simon Janes Antoine van Sint Fiet Giovanni Pintaldi
Medication-Assisted Therapy at Coleman Profession Services
Working with Adolescents: Additional Considerations
Department of Psychiatry Section of Population Behavioral Health
Screening, Brief Intervention and Referral to Treatment
Lesson 4: Test Your Knowledge
Screening, Brief Intervention and Referral to Treatment
Core Competency 4: HCV Treatment
C-SCOPE: Survey on the Management of HCV in addiction clinics treating Patients on Opiate Agonist Therapies: a global perspective July 2017.
Health Home Program Services
Peaceful Spirit Treatment Center
WHO WHAT WHE WHERE WHEN HOW WHY The PA SBIRT Vision:
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Strategic Initiatives to Address Opioid Overdose & Addiction
Substance Use Teaching Project (SUTP) “Action Plan” Introduction
Presentation transcript:

F/C AETC Faculty HIV HCV Thursday, March 12, 2015 | 1:30pm EDT Medical Facilitator/Didactic Presenter Todd S. Wills, MD University of South Florida Case Discussant Elizabeth Sherman, PharmD, AAHIVP Nova South Eastern University Maribel Gonzalez, MSN, ARNP-C University of South Florida Suzanne Stevens, MSW University of South Florida

Managing Addiction in HCV Patients Todd Wills, MD Associate Professor Infectious Disease and International Medicine University of South Florida F/C AETC Faculty Adapted from: Sulkowski, et al. A Guide for Evaluation and Treatment of Hepatitis C in Adults Coinfected with HIV. DHHS (HRSA) 2011 Unless otherwise noted

Assessment of Alcohol and Substance Abuse Ongoing Alcohol use? Amount? Ongoing Substance Abuse? Amount? How much use is acceptable? What are individual clinic protocols?

Evaluating and Modifying Obesity Obesity is associated with nonalcoholic fatty liver disease and steatosis Insulin resistance may diminish response to interferon What is the weight criteria for treatment initiation? What are individual clinic protocols?

Overcoming Barriers to Treatment Initiation Substance Abuse Counselors Opioid Dependence Treatment Patient Education Peer-Based Counseling Group Counseling Clinic Based Injections Any other specific clinic strategies?

Opioid Dependence Treatment methadone maintenance treatment diminishes and often eliminate opioid use buprenorphine office-based pharmacotherapy for opioid addiction physicians who complete a defined training can apply for a waiver to the Drug Addiction Treatment Act of 2000 National Institutes of Health Effective medical treatment of opiate addiction. NIH Consensus Statement 1997;15(6):1-38. Available at: Center for Substance Abuse Treatment Buprenorphine physician training events. Rockville, MD: Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services; Available at:

Alcohol Use Intervention Brief interventions by medical providers focused on problem use of alcohol client-centered counseling reflective listening nonjudgmental demeanor Core elements include: assessing current levels of consumption providing education regarding risks assessing and facilitating motivation to alter alcohol consumption Bhattacharya R, Shuhart MC Hepatitis C and alcohol: interactions, outcomes and implications. J Clin Gastroenterol 2003;36:242-52

Primary care Intervention

Primary Care Intervention toxicological and questionnaire screening brief motivational interviews active referrals a list of treatment providers follow-up booster phone call.

Patient Support Services Providing essential support services helps improve patient retention: case management transportation housing for the homeless Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care2002;14(Suppl 1):31-44.

Patient Support Services Specialized tools to improve adherence: electronic reminder system directly observed therapy cash incentives for attending scheduled medical appointments Lorvick J, Edlin BR Program and abstracts of the 128th annual meeting of the American Public Health Association (Boston). Washington, DC: American Public Health Association; Effectiveness of incentives in health interventions: what do we know from the literature? Jani AA, Bishai WR, Cohn SE, et al American Public Health Association and Health Resources and Services Administration Adherence to HIV treatment regimens: recommendations for best practices. Available at:

Project MATCH

Questions & Answers